Padron, Lacey J.; Maurer, Deena M.; O'Hara, Mark H.; O'Reilly, Eileen M.; Wolff, Robert A.; Wainberg, Zev A.; Ko, Andrew H.; Fisher, George; Rahma, Osama; Lyman, Jaclyn P.; Cabanski, Christopher R.; Yu, Jia Xin; Pfeiffer, Shannon M.; Spasic, Marko; Xu, Jingying; Gherardini, Pier Federico; Karakunnel, Joyson; Mick, Rosemarie; Alanio, Cecile; Byrne, Katelyn T.; Hollmann, Travis J.; Moore, Jonni S.; Jones, Derek D.; Tognetti, Marco; Chen, Richard O.; Yang, Xiaodong; Salvador, Lisa; Wherry, E. John; Dugan, Ute; O'Donnell-Tormey, Jill; Butterfield, Lisa H.; Hubbard-Lucey, Vanessa M.; Ibrahim, Ramy; Fairchild, Justin; Bucktrout, Samantha; LaVallee, Theresa M.; Vonderheide, Robert H.

CD4+T cells mediate non-canonical rejection of major histocompatibility class-I deficient pancreatic tumors independently of CD8+T cells

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

Multiplex microscopy reveals unique spatiotemporal effects of cancer immunotherapies

JOURNAL OF IMMUNOLOGY

IF3.4

2022-05-010

PRE

MULTIPLEX MICROSCOPY REVEALS UNIQUE SPATIOTEMPORAL EFFECTS OF CANCER IMMUNOTHERAPIES

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-100

Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

CLINICAL CANCER RESEARCH

IF10.2

2021-06-1094

OAAI

Byrne, Katelyn T.; Betts, Courtney B.; Mick, Rosemarie; Sivagnanam, Shamilene; Bajor, David L.; Laheru, Daniel A.; Chiorean, E. Gabriela; O'Hara, Mark H.; Liudahl, Shannon M.; Newcomb, Craig; Alanio, Cecile; Ferreira, Ana P.; Park, Byung S.; Ohtani, Takuya; Huffman, Austin P.; Vayrynen, Sara A.; Costa, Andressa Dias; Kaiser, Judith C.; Lacroix, Andreanne M.; Redlinger, Colleen; Stern, Martin; Nowak, Jonathan A.; Wherry, E. John; Cheever, Martin A.; Wolpin, Brian M.; Furth, Emma E.; Jaffee, Elizabeth M.; Coussens, Lisa M.; Vonderheide, Robert H.

Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40

NATURE COMMUNICATIONS

IF15.7

2021-06-08104

OAAI

cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes

cIAP1/2拮抗作用通过单核吞噬细胞的T细胞依赖性重编程消除MHC I类阴性肿瘤

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2021-05-1936

Roehle, Kevin; Qiang, Li; Ventre, Katherine S.; Heid, Daniel; Ali, Lestat R.; Lenehan, Patrick; Heckler, Max; Crowley, Stephanie J.; Stump, Courtney T.; Ro, Gabrielle; Godicelj, Anze; Bhuiyan, Aladdin M.; Yang, Annan; Del Rey, Maria Quiles; Biary, Tamara; Luoma, Adrienne M.; Bruck, Patrick T.; Tegethoff, Jana F.; Nopper, Svenja L.; Li, Jinyang; Byrne, Katelyn T.; Pelletier, Marc; Wucherpfennig, Kai W.; Stanger, Ben Z.; Akin, James J.; Mancias, Joseph D.; Agudo, Judith; Dougan, Michael; Dougan, Stephanie K.

Tumor Burden and Immunotherapy: Impact on Immune Infiltration and Therapeutic Outcomes

肿瘤负荷和免疫治疗: 对免疫浸润和治疗结果的影响

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-02-01113

OAAI

CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity

JCI INSIGHT

IF6.1

2020-05-2193

Katelyn T. Byrne

个人简介

教育背景

工作经历

荣誉奖项

研究方向